Tower Research Capital LLC (Trc) Cytosorbents Corp Transaction History
Tower Research Capital LLC (Trc)
- $4.07 Billion
- Q1 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Cytosorbents Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 8,024 shares of CTSO stock, worth $7,301. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,024
Previous 6,155
30.37%
Holding current value
$7,301
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding CTSO
# of Institutions
53Shares Held
17.8MCall Options Held
0Put Options Held
0-
Avenir Corp Washington, DC3.17MShares$2.89 Million0.27% of portfolio
-
Granahan Investment Management, LLC Waltham, MA3.04MShares$2.77 Million0.1% of portfolio
-
Skylands Capital, LLC2.88MShares$2.62 Million0.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.77 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.91MShares$1.74 Million0.0% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $39.7M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...